Implications for selectivity of 3,4-diarylquinolinones as p38αMAP kinase inhibitors

55Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this study we report on the specificity profiling of the MAP kinase inhibitors 1, 2, and 3 in a panel of 78 protein kinases including the MAPK isoforms p38(α,β,γ,δ), JNK1/2/3, and ERK1/2/8 showing 3-(4-fluorophenyl)-4-pyridin-4-ylquinolin-2(1H)-one (1) to be highly selective for p38αMAPK with an IC50 of 1.8 μM. In contrast, besides p38α the isoxazoles 2 and 3 significantly inhibited JNK2/3 and further kinases beyond the MAPK family such as PKA, PKD, Lck, and CK1. By using sequence alignment and homology models of different members of the MAPK family the binding mode determining selectivity of 1 for the p38α isoform was investigated. For lead optimization of 1 a straightforward tandem-Buchwald-aldol synthetic approach toward the flexible decoration of the quinolin-2(1H)-one scaffold was employed. SAR for derivatives of 1 at the isolated p38αMAPK are presented. © 2008 Elsevier Ltd. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Peifer, C., Urich, R., Schattel, V., Abadleh, M., Röttig, M., Kohlbacher, O., & Laufer, S. (2008). Implications for selectivity of 3,4-diarylquinolinones as p38αMAP kinase inhibitors. Bioorganic and Medicinal Chemistry Letters, 18(4), 1431–1435. https://doi.org/10.1016/j.bmcl.2007.12.073

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free